African Journal of Biomedical Research, Vol. 4, No. 3, Sept, 2001, pp. 155-157
Short Communication
USE OF BITOTS SPOT IN
SCREENING FOR VITAMIN A DEFICIENCY IN NIGERIAN CHILDREN
A.I. AJAIYEOBA1*
AND E.
SAMAILA2
1Department of
Ophthalmology, University College Hospital, Ibadan, NIGERIA.
2Guinness Eye Centre, Ahmadu Bello University Teaching Hospital,
Kaduna, NIGERIA.
*Address for correspondence
Received: January 2001
Accepted: September 2001
Code Number: md01072
A total of 2,905 children between 6
and 71 months of age were selected using a 2 stage stratified sampling method
and screened for xerophthalmia using World Health Organisation (WHO) criteria
and vitamin a deficiency (VAD) using serum retinol < 20 µg/dl
(low/marginal). Only 33 cases of xerophthalmia were seen representing a
national prevalence of 1.1%. Only 8 children presented with Bitots spots (XIB)
representing 0.3% of the total number of children screened for marginal VAD and
24.2% of xerophthalmic cases. Corneal xerosis (stage X2) was the commonest
(0.8%) ocular presentation amongst the total number of children screened and
also amongst cases of xerophthalmia where it was responsible for 66.7%. 3
children with VAD (serum retinol < 10 µg/dl) presented with Bitots spot,
corneal xerosis and corneal scar respectively. All of these 3 children were
severely malnourished and sick while one of them was moribund. No cases of
conjunctival xerosis (X1A), corneal ulcer (X3A) or keratomalacia (X3B) were
encountered in the study. Corneal scars (XS) attributable VAD was responsible
to 0.1%. Stages X3A (corneal xerosis) and XS (corneal scars attributable
toVAD) of xerophthalmia were above the WHO cut-off points. The national
prevalence of marginal VAD defined as serum retinol was 28.1%. Despite its low
prevalence, Bitots spot can be a useful screening tool particularly in a field
survey involving a large population of children because of the characteristic
cluster distribution of VAD. The implication of this is that a single case of
Bitots spot points to a whole community at risk of VAD.
Key words: Bitots spot, screening,
Vitamin A deficiency
INTRODUCTION
Vitamin A deficiency (VAD) is the
leading cause of childhood blindness in the world (Sommer et al., 1981) and is
a leading cause of morbidity and mortality among pre-school children in
developing countries (Beaton et al., 1981). Prevalence of xerophthalmia, the
ocular manifestation of VAD, has been considered the primary reference standard
for the assessment and determination of VAD as a public health problem (World
Health Organisation,1982). Ocular manifestation of VAD has been classified and
a detailed description of diagnostic techniques suitable for screening in field
surveys including criteria and interpretation is available (Sommer, 1982a).
Bitots spot consists of heaping of desquamated, keratinised epithelial cells,
which form a slightly raised area on the conjunctiva.
Bitots spot, one of the
ocular manifestations and most easily recognised, non-blinding signs of VAD
usually affecting children aged 3-6 years is a sign of longstanding deficiency,
which responds favourably to vitamin A could be a marker to identify those
communities with severe and longstanding VAD. Because of the clustering
(Sommer, 1982b) nature of VAD, identification of a single case of Bitots spot
may signify a community with VAD as a public health problem. It is therefore
desirable to evaluate the use of Bitots spot in screening for VAD in Nigerian
children.
MATERIALS AND METHODS
The survey was a population-based,
cross-sectional study, part of a national survey conducted in Nigeria between June and
September 1993, designed to estimate the prevalence of VAD and xerophthalmia in
the four health zones of Nigeria. Respondents were selected, using a two-stage stratified
cluster sampling method.
Ophthalmologists in most
areas did Screening and examination. However, in areas where ophthalmologists
were not available, ophthalmic residents and nurses did the screening. Both
ophthalmic residents and nurses were trained to apply a standardised
examination procedure. The screening/examination procedure followed the World
Health Organisation (WHO) criteria and staging (Wittpenn et al., 1988) of
xerophthalmia for field examination. Ophthalmic examination was carried out
with the aid of a pen torch and use of magnification (e.g. loupe). All
childrens eyes were stained with flourescein dye in order to assess subtle
corneal changes, which may be indicative of xerophthalmia. Blood samples
obtained from all children were assessed for retinol using the reversed phase,
high-pressure liquid chromatography (HPLC) method(Catignani and
Bierri, 1983).
Ethical approval for the
study was obtained from the Joint Ethical Committee of the College of Medicine,
University of Ibadan and the University College Hospital Ibadan, Nigeria. Informed
consents were obtained from mothers or guardians
after carefully explaining all procedures.
RESULTS
A total of 2905 children between 6
and 71 months of age were screened for xerophthalmia and VAD. However, data on
retinol of some children lacked details or vital information required for
meaningful analysis in some aspects of the study. These were largely due to
refusal of blood collection, inadequate/undesirable samples (haemolysed),
labelling errors, or improper/none entry of vital data. These records were
therefore excluded in order to improve the quality of the results. Therefore
only the retinol results of 1244 children were reliable for meaningful
evaluation.
Table 1: Prevalence of the
various stages of Xerophthalmia in Nigerian children with low/ marginal VAD
against the WHO cut-off points.
Stages of Xerophth
|
Frequency
|
%
|
% Indicative of public
health significance
|
No Xerophthalmia
XIA Conjunct. xerosis
XIB Bitots spot
X2 Corneal xerosis
X3A/B Corneal ulcer
XS Corneal scars
|
2872
0
8
22
0
3
|
98.8
0.0
0.3
0.8
0.0
0.1
|
<99 >
0.5 > 0.5 > 0.01 > 0.01 > 0.05
|
TOTAL
|
2905
|
100.0
|
|
Table 2: Prevalence of the various stages of
Xerophthalmia in Nigerian children with vitamin A deficiency.
Stages of xerophthalmia
|
No of children with
Retinol level
<10ug/dl (deficient)
|
No of children with
Retinol level > 10ug/dl
|
Total
|
No Xerophthalmia
XIA Conj. xerosis
XIB Bitot spot
X2 Corneal xerosis
X3A/B Corneal ulcer
XS Corneal scars
|
98
0
1
1
0
1
|
1130
0
1
12
0
0
|
1228 0 2 13 0 1
|
Total
|
101
|
1143
|
1244
|
Only 33 cases of
xerophthalmia were seen representing a national prevalence of 1.1%. Only 8
children presented with Bitots spots (XIB) representing 0.3% of the total
number of children screened for marginal VAD and 24.2% of xerophthalmic cases.
Corneal xerosis (stage X2) was the commonest (0.8%) ocular presentation amongst
the total number of children screened and also amongst cases of xerophthalmia
where it was responsible for 66.7%. No cases of conjunctival xerosis (X1A),
corneal ulcer (X3A) or keratomalacia (X3B) were encountered in the study.
Stages X3A (corneal xerosis) and XS (corneal scars attributable toVAD) of
Xerophthalmia were above the WHO cut-off points. The prevalence of the various
stages of xerophthalmia in children with low/marginal VAD (<20 ug/dl),
against the WHO cut-off points is shown in Table 1. 3 children with VAD (serum
retinal < 10 µg/dl) presented with Bitot spot, corneal xerosis and corneal
scar respectively. All the 3 children were severely malnourished and sick
while 1 was moribund. Table 2 shows the prevalence of the various stages of
xerophthalmia in children with VAD (retinol < 10 and > 10 ug/dl).
The national prevalence of
marginal vitamin A deficiency (defined by serum retinol < 20 µg/dl or 0.7
µmol/l) was 28.1% (95% confidence interval 25.4-31.0%) and severe retinol
deficiency (10 µg/dl or 0.35 µmol/l) was 7.0% (95% confidence interval
5.5-8.8%). The distribution curve was positively skewed and differed
significantly from the normal (Gaussian) pattern. The values ranged from 5 to
134 ug/dl. The national mean serum retinol value was 31.8 ug/dl. (SD= 18.6).
DISCUSSION
Xerophthalmia is the most readily
recognized clinical manifestation of Vitamin A deficiency (VAD) and has been
the most widely employed, definitive criteria for accessing weather Vitamin A
poses a significance public health problem. Xerophthalmia occurs when serum
levels drop below 20µg/dl, and is more likely when levels are below 10µg/dl.
Many of the eye signs of VAD are pathognomonic for the condition and so can be
used to diagnose and screen VAD. However not all children who were deficient
developed xerophthalmia (i.e. they were sub clinically deficient). This goes
to show that children who are clinically deficient and by definition have
xerophthalmia as well as those who are sub clinically deficient and but do not
develop xerophthalmia may both be vitamin A deficient. It therefore means that
those with xerophthalmia therefore only represent the tip of the iceberg of
those who are deficient in the community. However it has been documented that
children with clinical deficiency as well as those with sub-clinical deficiency
are at increased risk of dying(Sommer et al.,1983). It is therefore
important to have a sensitive marker like Bitots spot, which will lead us to
that community
When bitots spot is seen in children
over the age of 6 years, it may signify a previous early Vitamin A deficiency
and may therefore resemble cornea scars (XS). Both bitots spots and cornea
scars are reminiscences of early Vitamin A deficiency but differ from each
other in that, whereas bitot spot is specific for Vitamin A deficiency, cornea
scars may be due to other causes like trauma. Some workers (Mclaren, 1980) have
suggested the role of other ultra violet rays in particular in the genesis of
bitots spot, which it is usually located in the exposed part of the
conjunctiva.
Our finding in this study, of
a low prevalence of xerophthalmia including bitots spot despite the large
number of children screened has been the experience of other workers as well,
and has been documented(Sommer, 1982b). This low prevalence might
be due to the fact that ocular manifestation of xrophthalmia represents a long
term of severe and chronic effect of VAD on a target organ like the eye. Before
the manifestation of xerophthalmia, children must have suffered tremendously
from the systemic complications of VAD, which more often than not might have
claimed the lives of these children. It was therefore not surprising that all
the children with VAD presenting with xerophthalmia were sick children. Even
though bitot spot is a non-blinding condition, it is known (Sommer, 1983) that
children with bitots spot have a mortality rate which is 6.6 times greater
than children without it. In as much as we know that bitots spot is specific
for Vitamin A deficiency particularly when seen in children under 6 years of
age and because of the clustering nature of Vitamin A deficiency, it can be
inferred that a single case of bitots spot might signify a community with
vitamin A deficiency. However it would have been desirable to look at a larger
sample of children.
In conclusion, as has been shown that
children who are clinically deficient as well as those who are sub clinically
deficient are at increased risk of dying,(Sommer,1983) it is therefore
important to have a sensitive marker like Bitots spot which will lead us to
such community whose young generation may have been afflicted by a silent
killer. The overall health implication of this cannot be overemphasised.
REFERENCES